Metraipolis › archive › dc_fc789d1fc19d
Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma — Europe PMC PMID:42306568
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42306568
- DOI
- 10.1016/j.omton.2026.201239
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T10:28:46.663Z
- SHA-256 of the archived text
09fb4e21946f6a4d78a869ad4468bc6abd9014cfd8f08dc6c1ffd7720fe2414f- Stable URL of this page
https://metraipolis.com/documento/dc_fc789d1fc19d
How to cite
Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma — Europe PMC PMID:42306568 — Europe PMC (en), https://europepmc.org/article/MED/42306568 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc789d1fc19d (Metraipolis archive dc_fc789d1fc19d, sha256 09fb4e21946f6a4d78a869ad4468bc6abd9014cfd8f08dc6c1ffd7720fe2414f)
BibTeX
@misc{dcfc789d1fc19d,
title = {Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma — Europe PMC PMID:42306568},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42306568},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc789d1fc19d; sha256 09fb4e21946f6a4d78a869ad4468bc6abd9014cfd8f08dc6c1ffd7720fe2414f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42306568. Agents can read the archived copy with the MCP tool read_document.